Review of Automated Insulin Delivery Systems for Type 1 Diabetes and Associated Time in Range Outcomes.

ABSTRACT: Automated insulin delivery (AID) systems play an important role in the management of type 1 diabetes mellitus (T1DM). These systems include three components: a continuous glucose monitor (CGM), an insulin pump and an algorithm that adjusts the pump based on the CGM sensor glucose readings. They are not fully automated and still require the user to administer bolus insulin doses for food. Some AID systems have automatic correction boluses, while others only have automatic basal or background insulin adjustments. As CGM has become more accurate and the technology has evolved, AID systems have demonstrated improved glycaemic outcomes. The clinical evaluation of AID systems in randomized controlled trials and real-world studies have shown their utility in helping glycaemic management. In this

SUBMITTER: Nallicheri A 

PROVIDER: S-EPMC9354504 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature